Correctors (specific therapies for class II CFTR mutations) for cystic fibrosis

To evaluate the effects of CFTR correctors on clinically important outcomes in children and adults with CF. The clinically important outcomes will include both benefits and harms that participants may experience.

This is a protocol.

Share/Save